New SHIKARI® Mirikizumab and anti-Mirikizumab ELISA kits are out!

We are pleased to announce the launch of two new ELISA kits supporting research on mirikizumab (Omvoh®️), expanding the SHIKARI®️ portfolio to cover the latest IL-23 inhibitor used in inflammatory bowel disease research.

─────────────────────────────
SHIKARI®️ (Q-MIR) Mirikizumab ELISA | Cat. No.: MIR-FD-OMV
https://matriksbiotek.com/products/334/shikari-q-mir-mirikizumab-elisa 

Quantitative determination of mirikizumab in human serum and plasma — designed to cover the Cmin–Cmax concentration range for research applications studying drug exposure.

Key specs:
•⁠ ⁠Sample volume: 10 µL
•⁠ ⁠Total assay time: 135 min
•⁠ ⁠Detection limit: 0.6 ng/mL
•⁠ ⁠Spike recovery: 85–115%
•⁠ ⁠Samples per plate: 96
•⁠ ⁠Shelf life: 1 year | Shipped at room temperature

─────────────────────────────
SHIKARI®️ (S-ATMIR) Anti-Mirikizumab ELISA | Cat. No.: MIR-QLS-OMV
https://matriksbiotek.com/products/335/shikari-s-atmir-anti-mirikizumab-elisa 

Qualitative detection of antibodies to mirikizumab (Omvoh®️) in human serum and plasma — supporting immunogenicity research.

Key specs:
•⁠ ⁠Sample volume: 20 µL
•⁠ ⁠Total assay time: 140 min
•⁠ ⁠Assay type: Qualitative (positive/negative)
•⁠ ⁠Samples per plate: 96
•⁠ ⁠Shelf life: 1 year | Shipped at room temperature

─────────────────────────────
Together, these kits provide a complete research toolset for studying mirikizumab exposure and immunogenicity, supporting research in ulcerative colitis and Crohn's disease.

Both kits work with human serum and plasma samples and are stored at +4°C.

Orders & contact
EU orders: orders.matrix@matriksbiotek.com 
All other orders: order@matriksbiotek.com 
For more information: info@matriksbiotek.com  or matrix@matriksbiotek.com 

For Research Use Only. Not for use in diagnostic procedures.